Journal
VACCINE
Volume 35, Issue 44, Pages 5951-5955Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2017.03.032
Keywords
Yellow fever; Flavivirus; Vaccine; Fractional dosing; International health regulations
Categories
Ask authors/readers for more resources
Yellow fever (YF) is regarded as the original hemorrhagic fever and has been a major public health problem for at least 250 years. A very effective live attenuated vaccine, strain 17D, was developed in the 1930s and this has proved critical in the control of the disease. There is little doubt that without the vaccine, YF virus would be considered a biosafety level 4 pathogen. Significantly, YF is currently the only disease where an international vaccination certificate is required under the International Health Regulations. Despite having a very successful vaccine, there are occasional issues of supply and demand, such as that which occurred in Angola and Democratic Republic of Congo in 2016 when there was insufficient vaccine available. For the first time fractional dosing of the vaccine was approved on an emergency basis. Thus, continued vigilance and improvements in supply and demand are needed in the future. (C) 2017 Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available